Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia

American Journal of Epidemiology

Volumn 149, Issue 2, 1999, Pages 106-115

  Platz, Elizabeth A ^a   Rimm, Eric B ^a,b   Kawachi, Ichiro ^a,b   Colditz, Graham A ^a,b   Stampfer, Meir J ^a,b   Willett, Walter C ^a,b   Giovannucci, Edward ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Alcohol drinking; Cohort studies; Prostatectomy; Prostatic hyperplasia; Risk factors; Smoking

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CIGARETTE SMOKING; DISEASE CLASSIFICATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; URINARY TRACT OBSTRUCTION;

EID: 0033555525     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009775     Document Type: Article

References (47)

1. Bostwick D. Pathology of benign prostatic hyperplasia. In: Kirby R, McConnell J, Fitzpatrick J, et al, eds. Textbook of benign prostatic hyperplasia. Oxford: ISIS Medical Media, Ltd, 1996:91-104.
2. Graves EJ, Gillum BS. Detailed diagnoses and procedures, National Hospital Discharge Survey, 1995. Vital Health Stat 13 1997;130:1-146.
3. Girman C, Jacobsen S, Guess H, et al. Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. J Urol 1995;153:1510-15.
4. Simpson R, Fisher W, Lee A, et al. Benign prostatic hyperplasia in an unselected community-based population: a survey of urinary symptoms, bothersomeness and prostatic enlargement. Br J Urol 1996;77:186-91.
5. Caine M. The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy. J Urol 1986;136:1-4.
6. Ida Y, Tsujimaru S, Nakamaura K, et al. Effects of acute and repeated alcohol ingestion on hypothalamic-pituitary-gonadal and hypothalamic-pituitary-adrenal functioning in normal males. Drug Alcohol Depend 1992;31:57-64.
7. Mendelson J, Mello N, Ellingboe J. Effects of acute alcohol intake on pituitary-gonadal hormones in normal males. J Pharmacol Exp Ther 1977;202:676-82.
8. Gordon G, Altman K, Southren A, et al. Effect of alcohol (ethanol) administration on sex-hormone metabolism in normal men. N Engl J Med 1976;295:793-7.
9. Green G. Mechanism of hypogonadism in cirrhotic males. Gut 1977;18:843-53.
10. Reichman M, Judd J, Longcope C, et al. Effects of alcohol consumption on plasma and urinary hormone concentration in premenopausal women. J Natl Cancer Inst 1993;85:722-7.
11. Ginsburg E, Mello N, Mendelson J, et al. Effects of alcohol ingestion on estrogens in postmenopausal women. JAMA 1996;276:1747-51.
12. Dai WS, Gutai JP, Kuller LH, et al. Cigarette smoking and serum sex hormones in men. Am J Epidemiol 1988;128:796-805.
13. Field AE, Colditz GA, Willett WC, et al. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab 1994;79:1310-16.
14. Greenwald P, Kirmss V, Polan A, et al. Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst 1974;53:335-40.
15. Sidney S, Quesenberry C, Sadler M, et al. Risk factors for surgically treated benign prostatic hyperplasia in a prepaid health care plan. Urology 1991;38(suppl):13-19.
16. Morrison A. Risk factors for surgery for prostatic hypertrophy. Am J Epidemiol 1992;135:974-80.
17. Chyou P, Nomura A, Stemmermann G, et al. A prospective study of alcohol, diet, and other lifestyle factors in relation to obstructive uropathy. Prostate 1993;22:253-64.
18. Gann P, Hennekens C, Longcope C, et al. A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia. Prostate 1995;26:40-9.
19. Glynn RJ, Campion EW, Bouchard GR, et al. The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol 1985;121:78-90.
20. Lee E, Park M, Shin C, et al. A high-risk group for prostatism: a population-based epidemiological study in Korea. Br J Urol 1997;79:736-41.
21. Porta M, Fernandez E, Alonso J, et al. Re: Risk factors for benign prostatic hypertrophy. (Letter). Am J Epidemiol 1994;139:114-15.
22. Araki H, Watanabe H, Mishina T, et al. High-risk group for benign prostatic hypertrophy. Prostate 1983;4:253-64.
23. Seitter W, Barrett-Connor E. Cigarette smoking, obesity, and benign prostatic hypertrophy: a prospective population-based study. Am J Epidemiol 1992;135:500-3.
24. Daniell H. More stage A prostatic cancers, less surgery for benign hypertrophy in smokers. J Urol 1993;149:68-72.
25. Morrison A. Prostatic hypertrophy in greater Boston. J Chronic Dis 1978;31:357-62.
26. Ross R, Bernstein L, Paganini-Hill A, et al. Effects of cigarette smoking on "hormone related" disease in a southern California retirement community. In: Wald N, Baron J, eds. Smoking and hormone related disorders. Oxford: Oxford University Press, 1990:183-96.
27. Armenian H, Lilienfeld A, Diamond E, et al. Epidemiologic characteristics of patients with prostatic neoplasms. Am J Epidemiol 1975;102:47-54.
28. Roberts R, Jacobsen S, Rhodes T, et al. Cigarette smoking and prostatism: a biphasic association? Urology 1994;43:797-801.
29. Roberts R, Tsukamoto T, Kumamoto Y, et al. Association between cigarette smoking and prostatism in a Japanese community. Prostate 1997;30:154-9.
30. Barry M, Fowler F, O'Leary M, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992;148:1549-57.
31. Giovannucci E, Colditz G, Stampfer M, et al. The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol 1991;133:810-17.
32. Giovannucci E, Rimm E, Chute C, et al. Obesity and benign prostatic hypertrophy. Am J Epidemiol 1994;140:989-1002.
33. Platz E, Kawachi I, Rimm E, et al. Physical activity and benign prostatic hyperplasia. Arch Intern Med 1998;158:2349-56.
34. Kyprianou N, Davies P. Association states of androgen receptors in nuclei of human benign hypertrophic prostate. Prostate 1986;8:363-80.
35. Frydenberg M, Foo T, Jones A, et al. Benign prostatic hyperplasia-video image analysis and its relationship to androgen and epidermal growth factor receptor expression. J Urol 1991;146:872-6.
36. Peters C, Walsh P. The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia. N Engl J Med 1987;317:599-604.
37. Wilson J. The pathogenesis of benign prostatic hyperplasia. Am J Med 1980;68:745-56.
38. Imperato-McGinley J, Guerrero L, Gautier T, et al. Steroid 5-alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 1974;186:1213-15.
39. Andersson S, Berman DM, Jenkins EP, et al. Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature 1991;354:159-61.
40. Frea B, Annoscia S, Stanta G, et al. Correlation between liver cirrhosis and benign prostatic hyperplasia: a morphological study. Urol Res 1987;15:311-14.
41. Guess HA. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am 1995;22:247-61.
42. Grassi G, Somers V, Renk W, et al. Effects of alcohol intake on blood pressure and sympathetic nerve activity in normotensive humans: a preliminary report. J Hypertens 1989;7(suppl): S20-1.
43. Meikle A, Liu X, Taylor G, et al. Nicotine and cotinine effects on 3-alpha-hydroxysteroid dehydrogenase in canine prostate. Life Sci 1988;43:1845-50.
44. Mittler J, Pogach L, Ertel N. Effects of chronic smoking on testosterone metabolism in dogs. J Steroid Biochem 1983;18:759-63.
45. Daniell H. Larger prostatic adenomas in obese men with no associated increase in obstructive uropathy. J Urol 1993;149:315-17.
46. Matzkin H, Cytron S, Simon D. Is there an association between cigarette smoking and gland size in benign prostatic hyperplasia? Prostate 1996;29:42-5.
47. Haass M, Kubler W. Nicotine and sympathetic neurotransmission. Cardiovasc Drugs Ther 1997;10:657-65.